Clinical Pathway Following Fragility Fracture

1239
IOF, BJD, ISFR joined forces to produce a CD on fragility fracture which was launched at the EFORT congress in Florence, May 13, 2007.
Speakers at the EFORT congress included, from left to right: Dr. Karsten Dreinhöfer, Prof. Kristina Åkesson, Dr. Nansa Burlet, Prof. Wolfhart Puhl, Dr. Mary Bouxsein, Stephan Korte, Prof. David Marsh, Dr. Ghassan Maalouf

Orthopaedic surgeons are experts in operating fragility fractures and are continually looking for even better ways to surgically treat those fractures. However, surgeons often neglect to recommend that fracture patients evaluate their bone quality through a DXA exam. Access to treatment is, in most countries, dependent on the results of this diagnostic test. If patients are diagnosed with osteoporosis, it is of critical importance that they receive anti-osteoporosis drug treatment (proven effective and safe) which contributes to the prevention of future fractures and improved quality of life.

IOF, BJD, ISFR joined forces to produce a CD on fragility fracture which covers topics from pathology, epidemiology, and surgical concerns to clinical pathways to treat the underlying disease of osteoporosis.

The CD, which was launched at the EFORT congress in Florence and widely distributed to participants, can be downloaded on the three organizations’ websites so that the content can be used freely by all concerned anywhere in the world.

Many thanks is due to Novartis which provided a generous unrestricted grant towards the production of the CD.

Download Teaching Slide Kit